Literature DB >> 12903775

Arginine vasopressin gene expression in supraoptic nucleus and paraventricular nucleus of hypothalamous following cerebral ischemia and reperfusion.

X Liu1, Y Jin, H Zheng, G Chen, B Tan, B Wu.   

Abstract

BACKGROUND: Our previous studies indicated that the increased arginine vasopressin (AVP) in ischemic brain regions of gerbils could exacerbate the ischemic brain edema. This experiments is further clarify the relation between AVP and cerebral ischemia at the molecular level.
METHODS: The contents of AVP, AVP mRNA, AVP immunoreactive (ir) neurons in supraoptic nucleus(SON) and paraventricular nucleus (PVN) after cerebral ischemia and reperfusion were respectively determined by radioimmunoassay (RIA), immunocytochemistry (II C), situ hybridization and computed image pattern analysis.
RESULTS: The contents of AVP in SON, PVN were increased, and the AVP ir positive neurons in SON and PVN were also significantly increased as compared with the controls after ischemia and reperfusion. And there were very light staining of AVP ir positive neurons in the other brain areas such as suprachiasmatic nucleus (SC) and periventricular hypothalamic nucleus (PE), but these have no significant changes as compared with the controls. During different periods of cerebral ischemia (30 approximately 120 min) and reperfusion (30 min), AVP mRNA expression in SON and PVN were more markedly increased than the controls.
CONCLUSIONS: The transcription of AVP gene elevated, then promoting synthesis and release of AVP in SON, PVN. Under the specific condition of cerebral ischemia and reperfusion, the activity and contents of central AVP increased abnormally is one of the important factors which causes ischemia brain damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12903775

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  6 in total

1.  Multiple sites of vasopressin synthesis in the injured brain.

Authors:  Joanna Szmydynger-Chodobska; Brian J Zink; Adam Chodobski
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-20       Impact factor: 6.200

2.  Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury.

Authors:  Joanna Szmydynger-Chodobska; Leora M Fox; Kirsten M Lynch; Brian J Zink; Adam Chodobski
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

3.  Post-treatment with SR49059 improves outcomes following an intracerebral hemorrhagic stroke in mice.

Authors:  Anatol Manaenko; Nancy Fathali; Nikan H Khatibi; Tim Lekic; Kenneth J Shum; Robert Martin; John H Zhang; Jiping Tang
Journal:  Acta Neurochir Suppl       Date:  2011

4.  Sexual dimorphism in gene expression after aneurysmal subarachnoid hemorrhage.

Authors:  Victor Friedrich; Weina Bi; Fatima A Sehba
Journal:  Neurol Res       Date:  2015       Impact factor: 2.448

5.  Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

Authors:  Anatol Manaenko; Nancy Fathali; Nikan H Khatibi; Tim Lekic; Yu Hasegawa; Robert Martin; Jiping Tang; John H Zhang
Journal:  Neurochem Int       Date:  2011-01-20       Impact factor: 3.921

6.  Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.

Authors:  Xiaoqin Liu; Shin Nakayama; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.